Skip to main content

EDITORIAL article

Front. Mol. Neurosci.
Sec. Pain Mechanisms and Modulators
Volume 17 - 2024 | doi: 10.3389/fnmol.2024.1487141
This article is part of the Research Topic Molecular Neurobiology of Chronic Pain: Pharmacological and Non-Pharmacological Approaches in Animal Models View all 6 articles

Editorial: Molecular Neurobiology of Chronic Pain: Pharmacological and Non-Pharmacological Approaches in Animal Models.

Provisionally accepted
  • 1 Institute of Physiology, University of Bern, Bern, Switzerland
  • 2 Department of Neuroscience, Physiology and Pharmacology, University College London, London, England, United Kingdom
  • 3 Equipe Contrôle peptidergique des émotions Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France

The final, formatted version of the article will be published soon.

    Keywords: Gene Therapy, Chronic Pain, Non-pharmacological, Migraine, natural compounds

    Received: 27 Aug 2024; Accepted: 02 Sep 2024.

    Copyright: © 2024 Acuña, Valentinova and Darbon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Mario A. Acuña, Institute of Physiology, University of Bern, Bern, Switzerland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.